Infant Bacterial Therapeutics' Corporate Minority Round

Infant Bacterial Therapeutics raised a round of funding on September 07, 2015. Investors include BioGaia.

Infant Bacterial Therapeutics intends to develop the pharmaceutical drug candidate IBP-9414 for the prevention of NEC in premature infants.…

Articles about Infant Bacterial Therapeutics' Corporate Minority Round: